Aehr Test Systems (NASDAQ:AEHR) Short Interest Update

Aehr Test Systems (NASDAQ:AEHR) saw a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 5,810,000 shares, a decrease of 10.3% from the May 31st total of 6,480,000 shares. Based on an average daily volume of 991,800 shares, the short-interest ratio is presently 5.9 days.

Aehr Test Systems Trading Down 3.5 %

Shares of NASDAQ:AEHR opened at $10.71 on Wednesday. The company has a market capitalization of $309.73 million, a price-to-earnings ratio of 20.60 and a beta of 2.08. Aehr Test Systems has a 12 month low of $9.83 and a 12 month high of $54.10. The firm’s 50-day moving average is $11.72 and its 200 day moving average is $15.15.

Aehr Test Systems (NASDAQ:AEHR) last released its quarterly earnings data on Tuesday, April 9th. The semiconductor company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.01. The company had revenue of $7.56 million during the quarter, compared to analysts’ expectations of $7.60 million. Aehr Test Systems had a net margin of 21.43% and a return on equity of 18.70%. As a group, equities analysts forecast that Aehr Test Systems will post 0.4 EPS for the current fiscal year.

Institutional Investors Weigh In On Aehr Test Systems

Hedge funds have recently modified their holdings of the business. Rhumbline Advisers raised its stake in shares of Aehr Test Systems by 2.0% during the 3rd quarter. Rhumbline Advisers now owns 37,967 shares of the semiconductor company’s stock worth $1,735,000 after acquiring an additional 736 shares in the last quarter. UBS Group AG raised its stake in shares of Aehr Test Systems by 1.4% during the 3rd quarter. UBS Group AG now owns 69,180 shares of the semiconductor company’s stock worth $3,162,000 after acquiring an additional 924 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Aehr Test Systems by 6.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 16,018 shares of the semiconductor company’s stock worth $199,000 after acquiring an additional 961 shares in the last quarter. Artemis Investment Management LLP raised its stake in shares of Aehr Test Systems by 12.4% during the 4th quarter. Artemis Investment Management LLP now owns 12,916 shares of the semiconductor company’s stock worth $343,000 after acquiring an additional 1,422 shares in the last quarter. Finally, Deutsche Bank AG raised its stake in shares of Aehr Test Systems by 12.9% during the 3rd quarter. Deutsche Bank AG now owns 13,863 shares of the semiconductor company’s stock worth $634,000 after acquiring an additional 1,588 shares in the last quarter. Hedge funds and other institutional investors own 69.69% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. William Blair reiterated a “market perform” rating on shares of Aehr Test Systems in a report on Monday, March 25th. Craig Hallum reiterated a “hold” rating and set a $12.00 price target on shares of Aehr Test Systems in a report on Tuesday, March 26th. Finally, StockNews.com downgraded shares of Aehr Test Systems from a “hold” rating to a “sell” rating in a report on Thursday, April 11th.

Aehr Test Systems Company Profile

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.